Stay updated on Jaktinib Hydrochloride Tablets in IPF Clinical Trial
Sign up to get notified when there's something new on the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page.

Latest updates to the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page
- Check3 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 on the page displaying a 403 Forbidden error.SummaryDifference0.2%

- Check9 days agoChange DetectedThe footer’s displayed ClinicalTrials.gov revision changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record, signaling an access issue or site block; the surrounding site chrome remains, but the main content is replaced.SummaryDifference18%

- Check52 days agoChange DetectedRevision tag on the page updated from v3.6.5 to v3.6.6, indicating a newer build of the study details page. No study content or data were changed.SummaryDifference0.1%

- Check73 days agoChange DetectedPage revision changed from v3.6.4 to v3.6.5, signaling a minor update to the page's template or rendering process; no study details appear to be altered.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, reflecting a site software/template update. This does not modify study content or visible information for participants.SummaryDifference0.1%

Stay in the know with updates to Jaktinib Hydrochloride Tablets in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page.